Bio-Techne Leads Key Proteomic Reagent Markets
Narrow moat Bio-Techne is a market leader in proteins, immunoassays, clinical diagnostic controls, and other reagents that are crucial for the academic, biopharmaceutical, and diagnostic markets.
Narrow moat Bio-Techne is a market leader in proteins, immunoassays, clinical diagnostic controls, and other reagents that are crucial for the academic, biopharmaceutical, and diagnostic markets.
The firm's reputation for excellent proteomic reagents and instruments allow it to generate high profit margins and strong cash flow.
Bio-Techne's long-term strategy relies on acquisitions, and the company may have difficulty finding suitable targets due to high valuations or scarcity. Additionally, it may fail to successfully integrate and scale up an acquired business.
Metric
|
TECH
|
BIO
|
TMO
|
---|---|---|---|
Price/Earnings (Normalized) | 42.00 | 31.74 | 27.41 |
Price/Book Value | 5.72 | 1.43 | 4.82 |
Price/Sales | 10.37 | 3.85 | 5.45 |
Price/Cash Flow | 38.90 | 10.04 | 26.84 |
Metric
|
TECH
|
BIO
|
TMO
|
---|---|---|---|
Quick Ratio | 2.47 | 4.23 | 1.24 |
Current Ratio | 3.87 | 6.28 | 1.72 |
Interest Coverage | 12.59 | −35.80 | 4.91 |
Metric
|
TECH
|
BIO
|
TMO
|
---|---|---|---|
Return on Assets (Normalized) | 10.51% | 2.66% | 8.68% |
Return on Equity (Normalized) | 14.22% | 3.75% | 18.42% |
Return on Invested Capital (Normalized) | 11.85% | 2.93% | 10.79% |
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Novo Nordisk AS ADR
NVO
| Tycmybpclr | Btr | $512.4 Bil | |||
Vertex Pharmaceuticals Inc
VRTX
| Tzwrdkskp | Hyhhtj | $117.5 Bil | |||
Regeneron Pharmaceuticals Inc
REGN
| Mfdrxwpr | Dlltkh | $111.6 Bil | |||
Alnylam Pharmaceuticals Inc
ALNY
| Xnvwgrb | Gjqthrc | $34.4 Bil | |||
argenx SE ADR
ARGX
| Ywxsjkydg | Xhx | $31.7 Bil | |||
BioNTech SE ADR
BNTX
| Xqsxgrpc | Zvzlw | $29.2 Bil | |||
Moderna Inc
MRNA
| Wlvxtyc | Szm | $23.1 Bil | |||
United Therapeutics Corp
UTHR
| Jlcjdqzcx | Bpkwy | $15.8 Bil | |||
Biomarin Pharmaceutical Inc
BMRN
| Sgzrhwgwm | Vdsvv | $13.2 Bil | |||
Incyte Corp
INCY
| Pshkxzd | Tfzvgfy | $13.0 Bil |